Christopher J. Novosad
Examiner (ID: 10390, Phone: (571)272-6993 , Office: P/3671 )
| Most Active Art Unit | 3671 |
| Art Unit(s) | 3671, 3616, 3501, 3641, 2899 |
| Total Applications | 3135 |
| Issued Applications | 2776 |
| Pending Applications | 115 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6782999
[patent_doc_number] => 20030064446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/194460
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61087
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064446.pdf
[firstpage_image] =>[orig_patent_app_number] => 10194460
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/194460 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 10, 2002 | Abandoned |
Array
(
[id] => 6778662
[patent_doc_number] => 20030049743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/194394
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61115
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049743.pdf
[firstpage_image] =>[orig_patent_app_number] => 10194394
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/194394 | PRO9822 antibodies | Jul 10, 2002 | Issued |
Array
(
[id] => 6783000
[patent_doc_number] => 20030064447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/194463
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61087
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064447.pdf
[firstpage_image] =>[orig_patent_app_number] => 10194463
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/194463 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 10, 2002 | Abandoned |
Array
(
[id] => 6706303
[patent_doc_number] => 20030153037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/194457
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61105
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153037.pdf
[firstpage_image] =>[orig_patent_app_number] => 10194457
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/194457 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 10, 2002 | Abandoned |
Array
(
[id] => 322295
[patent_doc_number] => 07517525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-14
[patent_title] => 'Methods of inhibiting amyloid toxicity'
[patent_app_type] => utility
[patent_app_number] => 10/190548
[patent_app_country] => US
[patent_app_date] => 2002-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18782
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/517/07517525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10190548
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/190548 | Methods of inhibiting amyloid toxicity | Jul 8, 2002 | Issued |
Array
(
[id] => 424836
[patent_doc_number] => 07270818
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-18
[patent_title] => 'Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of DMS'
[patent_app_type] => utility
[patent_app_number] => 10/186681
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7751
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/270/07270818.pdf
[firstpage_image] =>[orig_patent_app_number] => 10186681
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/186681 | Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of DMS | Jul 1, 2002 | Issued |
Array
(
[id] => 6688396
[patent_doc_number] => 20030032121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/180547
[patent_app_country] => US
[patent_app_date] => 2002-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 57442
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032121.pdf
[firstpage_image] =>[orig_patent_app_number] => 10180547
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/180547 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jun 24, 2002 | Abandoned |
Array
(
[id] => 6688395
[patent_doc_number] => 20030032120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/180546
[patent_app_country] => US
[patent_app_date] => 2002-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 57327
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032120.pdf
[firstpage_image] =>[orig_patent_app_number] => 10180546
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/180546 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jun 24, 2002 | Abandoned |
Array
(
[id] => 6825201
[patent_doc_number] => 20030235823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation'
[patent_app_type] => new
[patent_app_number] => 10/177104
[patent_app_country] => US
[patent_app_date] => 2002-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 29833
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20030235823.pdf
[firstpage_image] =>[orig_patent_app_number] => 10177104
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/177104 | Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation | Jun 23, 2002 | Abandoned |
| 10/049182 | Modulation of the blood-brain barrier transporter for leptin | Jun 18, 2002 | Abandoned |
Array
(
[id] => 6735558
[patent_doc_number] => 20030013193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Method of producing region-specific neurons from human neuronal stem cells'
[patent_app_type] => new
[patent_app_number] => 10/176971
[patent_app_country] => US
[patent_app_date] => 2002-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11508
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013193.pdf
[firstpage_image] =>[orig_patent_app_number] => 10176971
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/176971 | Method of producing region-specific neurons from human neuronal stem cells | Jun 18, 2002 | Issued |
Array
(
[id] => 6745111
[patent_doc_number] => 20030022294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/175738
[patent_app_country] => US
[patent_app_date] => 2002-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 57473
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022294.pdf
[firstpage_image] =>[orig_patent_app_number] => 10175738
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175738 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jun 18, 2002 | Abandoned |
Array
(
[id] => 6745025
[patent_doc_number] => 20030022208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/160293
[patent_app_country] => US
[patent_app_date] => 2002-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 19249
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022208.pdf
[firstpage_image] =>[orig_patent_app_number] => 10160293
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/160293 | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | Jun 3, 2002 | Abandoned |
Array
(
[id] => 7083810
[patent_doc_number] => 20050049190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Cation conducting gabaa receptors and their use'
[patent_app_type] => utility
[patent_app_number] => 10/479251
[patent_app_country] => US
[patent_app_date] => 2002-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4826
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049190.pdf
[firstpage_image] =>[orig_patent_app_number] => 10479251
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/479251 | Cation conducting GABAA receptors and their use | Jun 3, 2002 | Issued |
Array
(
[id] => 6519283
[patent_doc_number] => 20020192219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Morphogenic proteins'
[patent_app_type] => new
[patent_app_number] => 10/159749
[patent_app_country] => US
[patent_app_date] => 2002-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10274
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192219.pdf
[firstpage_image] =>[orig_patent_app_number] => 10159749
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/159749 | Morphogenic proteins | May 28, 2002 | Abandoned |
Array
(
[id] => 6725063
[patent_doc_number] => 20030207375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/146794
[patent_app_country] => US
[patent_app_date] => 2002-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63508
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207375.pdf
[firstpage_image] =>[orig_patent_app_number] => 10146794
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/146794 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 14, 2002 | Abandoned |
Array
(
[id] => 517596
[patent_doc_number] => 07193074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-20
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/063702
[patent_app_country] => US
[patent_app_date] => 2002-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 168
[patent_figures_cnt] => 168
[patent_no_of_words] => 44531
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/193/07193074.pdf
[firstpage_image] =>[orig_patent_app_number] => 10063702
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/063702 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 7, 2002 | Issued |
Array
(
[id] => 6755668
[patent_doc_number] => 20030003445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Method of preventing cell death using antibodies to neural thread proteins'
[patent_app_type] => new
[patent_app_number] => 10/138516
[patent_app_country] => US
[patent_app_date] => 2002-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15606
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20030003445.pdf
[firstpage_image] =>[orig_patent_app_number] => 10138516
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/138516 | Method of preventing cell death using antibodies to neural thread proteins | May 5, 2002 | Abandoned |
Array
(
[id] => 6829846
[patent_doc_number] => 20030180904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/063565
[patent_app_country] => US
[patent_app_date] => 2002-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 169
[patent_figures_cnt] => 169
[patent_no_of_words] => 45528
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180904.pdf
[firstpage_image] =>[orig_patent_app_number] => 10063565
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/063565 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 1, 2002 | Abandoned |
Array
(
[id] => 6814271
[patent_doc_number] => 20030073821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/063566
[patent_app_country] => US
[patent_app_date] => 2002-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 169
[patent_figures_cnt] => 169
[patent_no_of_words] => 40754
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073821.pdf
[firstpage_image] =>[orig_patent_app_number] => 10063566
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/063566 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 1, 2002 | Abandoned |